January 12, 2022
Takeda Pharmaceutical is acquiring London-based Adaptate Biotherapeutics, which focuses on gamma-delta (γδ) T cell engager therapies, in a bid to augment its R&D efforts on immuno-oncology. The Japanese mega pharma said on January 10 that it has exercised its option...read more